Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02174614 · ClinicalTrials.gov registry record · Phase 1

The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT)

A Phase 1 study of Cocaine Use Disorder, sponsored by Yale University.

Completed
Registry status
Phase 1
Development phase
99
Enrollment target
2
Study locations

NCT02174614 is a Phase 1 study of Cocaine Use Disorder that has completed, run by Yale University. The registered enrollment target is 99 participants, roughly in line with the 100-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02174614, a Phase 1 study of Cocaine Use Disorder, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 1
Development phase
99 participants
Enrollment target
2
Study locations

Study Summary

The investigators are conducting a randomized clinical trial of rapid abstinence initiation and cognitive control training as a precursor to our new web-based version of the CBT4CBT (Computer Based Training for Cognitive Behavioral Therapy) program to evaluate its effectiveness relative to standard outpatient counseling at the Midwestern Connecticut Council of Alcoholism (MCCA). CCT will be used to assess attention, working memory and inhibitory control and the computer-based training program (CBT4CBT) focuses on teaching basic coping skills, presenting examples of effective use of coping skills in a number of realistic situations in video form, and providing opportunities for patients to practice and review new skills while receiving cocaine abuse treatment.

Conditions Studied

Cocaine Use Disorder

Interventions

  • BEHAVIORAL Treatment As Usual (TAU)
  • BEHAVIORAL TAU plus Rapid Abstinence Initiation (RAI)
  • BEHAVIORAL TAU plus RAI plus Cognitive Control Training (CCT)

Study Locations (2)

Connecticut

  • MCCA - Bridgeport
  • MCCA - New Haven

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2015-04
Est. Completion 2020-08-31
Phase Phase 1

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02174614

The ClinicalTrials.gov registry entry for NCT02174614 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 100-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Treatment As Usual (TAU) is the first listed.

NCT02174614 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02174614 about?

NCT02174614 is a clinical study titled "The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT)". The investigators are conducting a randomized clinical trial of rapid abstinence initiation and cognitive control training as a precursor to our new web-based version of the CBT4CBT (Computer Based Training for Cognitive Behavioral Therapy) program to evaluate its effectiveness relative to standard ...

What is the current status of trial NCT02174614?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 99 participants. The study started on 2015-04. Estimated completion is 2020-08-31.

What conditions does trial NCT02174614 study?

This clinical trial studies the following conditions: Cocaine Use Disorder.

What interventions are being tested in trial NCT02174614?

The interventions under investigation include: Treatment As Usual (TAU) (BEHAVIORAL), TAU plus Rapid Abstinence Initiation (RAI) (BEHAVIORAL), TAU plus RAI plus Cognitive Control Training (CCT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02174614?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02174614 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cocaine Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cocaine Use Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.